Assessment of the interaction procedure between Pt(IV) prodrug [Pt(5,5′-dmbpy)Cl₄ and human serum albumin: Combination of spectroscopic and molecular modeling technique

References

• Abedi, A., Safari, N., Amani, V., Tavajohi, S., & Ostad, S. N. (2011). Synthesis, characterization and cytotoxicity of a series of tetrachloridoplatinum (IV) complexes. Inorganica Chimica Acta, 376, 679–686.10.1016/j.ica.2011.07.022
   Web of Science ®Google Scholar
• Amani, V., Safari, N., Khavasi, H. R., & Akkurt, M. (2009). Synthesis, characterization and crystal structure determination of platinum (IV) complexes containing, bipyridine derivatives and chloride,[Pt (5,5′-dmbipy) Cl4] and [Pt (6-mbipy) Cl 4]. Polyhedron, 28, 3026–3030.10.1016/j.poly.2009.06.053
   Web of Science ®Google Scholar
• Anderson, W., Quagliato, D., Haugwitz, R., Narayanan, V., & Wolpert-DeFilippes, M. (1986). Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum (IV) stereoisomers of 1, 2-diaminocyclohexane. Cancer treatment reports, 70, 997–1002.
   PubMedGoogle Scholar
• Bourassa, P., Dubeau, S., Maharvi, G. M., Fauq, A. H., Thomas, T., & Tajmir-Riahi, H. (2011). Binding of antitumor tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen to human serum albumin. Biochimie, 93, 1089–1101.10.1016/j.biochi.2011.03.006
   PubMed Web of Science ®Google Scholar
• Carter, D. C., & Ho, J. X. (1994). Structure of serum albumin. Advances in Protein Chemistry, 45, 153–203.10.1016/S0065-3233(08)60640-3
   PubMedGoogle Scholar
• Chuang, V. T. G., Kragh-Hansen, U., & Otagiri, M. (2002). Pharmaceutical strategies utilizing recombinant human serum albumin. Pharmaceutical Research, 19, 569–577.10.1023/A:1015396825274
   PubMed Web of Science ®Google Scholar
• Ding, F., Liu, W., Diao, J.-X., Yin, B., Zhang, L., & Sun, Y. (2011). Complexation of insecticide chlorantraniliprole with human serum albumin: Biophysical aspects. Journal of Luminescence, 131, 1327–1335.10.1016/j.jlumin.2011.03.007
   Web of Science ®Google Scholar
• Eastman, A. (1987). Glutathione-mediated activation of anticancer platinum (IV) complexes. Biochemical Pharmacology, 36, 4177–4178.10.1016/0006-2952(87)90581-8
   PubMed Web of Science ®Google Scholar
• Faridbod, F., Ganjali, M. R., Larijani, B., Riahi, S., Saboury, A. A., Hosseini, M., … Pillip, C. (2011). Interaction study of pioglitazone with albumin by fluorescence spectroscopy and molecular docking. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 78, 96–101.10.1016/j.saa.2010.09.001
   PubMed Web of Science ®Google Scholar
• Ghasemi, J. B., Abdolmaleki, A., & Shiri, F. (2016). Molecular docking challenges and limitations. In B. Sokouti (Ed.), Applied case studies and solutions in molecular docking-based drug design (pp. 56–80). Hershey, PA: IGI Global.10.4018/978-1-5225-0362-0
   Google Scholar
• Hall, M. D., & Hambley, T. W. (2002). Platinum (IV) antitumour compounds: Their bioinorganic chemistry. Coordination Chemistry Reviews, 232, 49–67.10.1016/S0010-8545(02)00026-7
   Web of Science ®Google Scholar
• Hu, Y. J., Liu, Y., Wang, J.-B., Xiao, X.-H., & Qu, S.-S. (2004). Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. Journal of Pharmaceutical and Biomedical Analysis, 36, 915–919.10.1016/j.jpba.2004.08.021
   PubMed Web of Science ®Google Scholar
• Huang, B. X., Kim, H.-Y., & Dass, C. (2004). Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry. Journal of the American Society for Mass Spectrometry, 15, 1237–1247.10.1016/j.jasms.2004.05.004
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267, 727–748.10.1006/jmbi.1996.0897
   PubMed Web of Science ®Google Scholar
• Kandagal, P., Ashoka, S., Seetharamappa, J., Shaikh, S., Jadegoud, Y., & Ijare, O. (2006). Study of the interaction of an anticancer drug with human and bovine serum albumin: Spectroscopic approach. Journal of Pharmaceutical and Biomedical Analysis, 41, 393–399.10.1016/j.jpba.2005.11.037
   PubMed Web of Science ®Google Scholar
• Li, D., Zhu, J., Jin, J., & Yao, X. (2007). Studies on the binding of nevadensin to human serum albumin by molecular spectroscopy and modeling. Journal of Molecular Structure, 846, 34–41.10.1016/j.molstruc.2007.01.020
   Web of Science ®Google Scholar
• Lakowicz, J. R. (1999). Introduction to fluorescence: Principles of fluorescence spectroscopy. Springer.
   Google Scholar
• Mallick, A., Haldar, B., & Chattopadhyay, N. (2005). Spectroscopic investigation on the interaction of ICT probe 3-acetyl-4-oxo-6, 7-dihydro-12H indolo-[2, 3-a] quinolizine with serum albumins. The Journal of Physical Chemistry B, 109, 14683–14690.10.1021/jp051367z
   PubMed Web of Science ®Google Scholar
• Miller, J. (1983). Photoluminescence and chemiluminescence methods of drug analysis. Journal of Pharmaceutical and Biomedical Analysis, 1, 525–535.10.1016/0731-7085(83)80066-1
   PubMedGoogle Scholar
• O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open babel: An open chemical toolbox. Journal of cheminformatics, 3(1), 1–14.
   PubMed Web of Science ®Google Scholar
• Pouryasin, Z., Yousefi, R., Nabavizadeh, S. M., Rashidi, M., Hamidizadeh, P., Alavianmehr, M.-M., & Moosavi-Movahedi, A. A. (2014). Anticancer and DNA binding activities of platinum (IV) complexes; importance of leaving group departure rate. Applied Biochemistry and Biotechnology, 172, 2604–2617.10.1007/s12010-013-0700-6
   PubMed Web of Science ®Google Scholar
• Quevedo, M. A., Moroni, G. N., & Briñón, M. C. (2001). Human serum albumin binding of novel antiretroviral nucleoside derivatives of AZT. Biochemical and Biophysical Research Communications, 288, 954–960.10.1006/bbrc.2001.5878
   PubMed Web of Science ®Google Scholar
• Ross, P. D., & Subramanian, S. (1981). Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, 20, 3096–3102.10.1021/bi00514a017
   PubMed Web of Science ®Google Scholar
• Shahraki, S., Shiri, F., Mansouri-Torshizi, H., & Shahraki, J. (2016). Characterization of the interaction between a platinum(II) complex and human serum albumin: Spectroscopic analysis and molecular docking. Journal of the Iranian Chemical Society, 13, 723–731.10.1007/s13738-015-0784-8
   Web of Science ®Google Scholar
• Smith, J. H., Smith, M. A., Litterst, C. L., Copley, M. P., Uozumi, J., & Boys, M. R. (1988). Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP and cisplatin at equimolar doses in the ficher 344 rat. Toxicological Sciences, 10, 45–61.10.1093/toxsci/10.1.45
   Google Scholar
• Smith, M., Smith, J., Litterst, C., Copley, M., Uozumi, J., & Boyd, M. (1988). In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the F-344 rat. Toxicological Sciences, 10, 62–72.
   Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461.
   PubMed Web of Science ®Google Scholar
• Trynda-Lemiesz, L., Karaczyn, A., Keppler, B. K., & Kozlowski, H. (2000). Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate(III). Journal of Inorganic Biochemistry, 78, 341–346.10.1016/S0162-0134(00)00062-3
   PubMed Web of Science ®Google Scholar
• Verdonk, M. L., Berdini, V., Hartshorn, M. J., Mooij, W. T., Murray, C. W., Taylor, R. D., & Watson, P. (2004). Virtual screening using protein−ligand docking:  Avoiding artificial enrichment. Journal of Chemical Information and Computer Sciences, 44, 793–806.10.1021/ci034289q
   PubMedGoogle Scholar
• Ward, L. D. (1985). Measurement of ligand binding to proteins by fluorescence spectroscopy. Methods in Enzymology, 117, 400–414.10.1016/S0076-6879(85)17024-2
   PubMed Web of Science ®Google Scholar
• Yousefi, R., Mohammadi, R., Taheri-Kafrani, A., Shahsavani, M. B., Aseman, M. D., Nabavizadeh, S. M., … Moosavi-Movahedi, A.-A. (2015). Study of the interaction between two newly synthesized cyclometallated platinum (II) complexes and human serum albumin: Spectroscopic characterization and docking simulation. Journal of Luminescence, 159, 139–146.10.1016/j.jlumin.2014.10.055
   Web of Science ®Google Scholar
• Yue, Y., Chen, X., Qin, J., & Yao, X. (2009). Spectroscopic investigation on the binding of antineoplastic drug oxaliplatin to human serum albumin and molecular modeling. Colloids and Surfaces B: Biointerfaces, 69, 51–57.10.1016/j.colsurfb.2008.10.016
   PubMed Web of Science ®Google Scholar
• Zhang, G., Wang, Y., Zhang, H., Tang, S., & Tao, W. (2007). Human serum albumin interaction with paraquat studied using spectroscopic methods. Pesticide Biochemistry and Physiology, 87, 23–29.10.1016/j.pestbp.2006.05.003
   Web of Science ®Google Scholar
• Zhu, L., Yang, F., Chen, L., Meehan, E. J., & Huang, M. (2008). A new drug binding subsite on human serum albumin and drug–drug interaction studied by X-ray crystallography. Journal of Structural Biology, 162, 40–49.10.1016/j.jsb.2007.12.004
   PubMed Web of Science ®Google Scholar